Get the Stockscreener App
120.94
0.88%
-1.07
Pre-market:
120.53
-0.41
-0.34%
State Street Spdr S P Biotech Etf stock is traded at $120.94, with a volume of 7.62M.
It is down -0.88% in the last 24 hours and up +5.32% over the past month.
See More
Previous Close:
$122.01
Open:
$122.19
24h Volume:
7.62M
Relative Volume:
0.72
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.91%
1M Performance:
+5.32%
6M Performance:
+47.31%
1Y Performance:
+27.86%
1-Day Range:
$120.81
$122.99
1-Week Range:
$120.81
$124.53
52-Week Range:
$66.66
$125.87
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
Name
State Street Spdr S P Biotech Etf
Sector
Industry
Phone
-
Address
-
Compare XBI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBI
State Street Spdr S P Biotech Etf
|
120.94 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
330.71 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
671.40 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
672.41 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
258.44 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
600.41 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf Stock (XBI) Latest News
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)? - MSN
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
I'm Eyeing One Big, One Little Biotech for a Repeat Trade - TheStreet Pro
Should You Invest in the iShares Biotechnology ETF (IBB)? - sharewise.com
Two Sector ETFs Are Quietly Outperforming the S&P 500 Without a Single AI Stock - AOL.com
2 Brilliant Biotech ETFs to Watch in 2026 - AOL.com
Biotech ETFs Gain Momentum with Promising Gains and Risks - cointurk finance
Should you invest in the State Street SPDR S&P Regional Banking ETF (KRE)? - MSN
Eight stock picks to play one of the healthiest corners of the market - MarketWatch
Opinion: The Fed cut rates. Biotech didn’t notice. - MarketWatch
3 Undervalued ETFs to Buy Before 2026 - Yahoo Finance
Biotech ETF (XBI) Hits New 52-Week High - TradingView — Track All Markets
The Biotech Industry Is Healthier Than Investors Think. The Stocks to Watch. - Barron's
Meet the New AI Winners: Alphabet, Tesla and Even Big Pharma and Biotech - Barron's
1 Sector ETF to Avoid Like the Plague in November - AOL.com
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - sharewise.com
ETFs Investing in ArriVent BioPharma, Inc. Stocks - TradingView
Gold Miners Are Crushing Gold: UBS Says Grab These 5 Cheap Picks - AOL.com
IYK vs. XLP: Top Holdings Could Make the Difference - AOL.com
State Street SPDR and iShares ETFs Deliver Strong Growth Without AI Stocks - cointurk finance
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - sharewise.com
This Fund Leaned Into 2025's Big Biotech Rally with a $9.5 Million Bet on Mineralys - AOL.com
Biotech Fund Dumps $12.3 Million in Crinetics Stock as Shares Remain 19% Lower on the Year - AOL.com
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Apple, Taiwan Semiconductor Manufacturing And More On CNBC's 'Final Trades' - Benzinga
The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI - sharewise.com
Best-Performing ETFs of Last Week: Healthcare Rules - sharewise.com
Why biotech and drug stocks are on the mend even though the rest of the market is hurting - MSN
3 Biotech Stocks Wall Street Analysts Predict Will More Than Double - MSN
ETFs Investing in Janux Therapeutics, Inc. Stocks - TradingView
S&P 500: Health Care Stocks Come Alive — Nudging Tech Aside For Now - Investor's Business Daily
Biotech Stock Gets Booted in Latest Fund Update - AOL.com
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - sharewise.com
(11/19/25) PFE: The Winner in the Metsera Bidding War - moneyshow.com
Why biotech and drug stocks are rallying even though the rest of the market is hurting - MSN
M&A Injects Life Into Biotech Trade - TheStreet Pro
XBI: Biotech Funding Condition Recovery Could Be Overdue (NYSEARCA:XBI) - Seeking Alpha
XBI: An Equal Weight ETF On Biotech That Amplifies Its Speculative Component - Seeking Alpha
Breakthrough bets on life sciences rebound with $430m fundraise - Private Equity Real Estate | PERE
This Biotech Stock Soared 100%. Merck Is Buying It. - Barron's
META_TITLE_SECTORS - Yahoo Finance
State Street Spdr S P Biotech Etf Stock (XBI) Financials Data
There is no financial data for State Street Spdr S P Biotech Etf (XBI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):